Xgeva. XGEVA is a prescription medicine used to prevent fracture spinal cord compression or the need for radiation or surgery to bone in patients with multiple myeloma and in patients with bone metastases from solid tumors. Denosumab trade names Prolia and Xgeva is a human monoclonal antibody for the treatment of osteoporosis treatment-induced bone loss metastases to bone and giant cell tumor of bone.
For more detail see How denosumab works section below. The Xgeva brand of denosumab is used to prevent bone fractures and other skeletal conditions in people with multiple myeloma and in people with tumors that have spread to the bone. Denosumab has an approximate molecular weight of 147 kDa and is produced in genetically engineered mammalian Chinese hamster ovary cells.
Denosumab has an approximate molecular weight of 147 kDa and is produced in genetically engineered mammalian Chinese hamster ovary cells.
Xgeva is a brand-name prescription medication. Denosumab trade names Prolia and Xgeva is a human monoclonal antibody for the treatment of osteoporosis treatment-induced bone loss metastases to bone and giant cell tumor of bone. Xgeva denosumab Injection is a human IgG2 monoclonal antibody used to treat bone problems that may occur with cancer that has spread metastasized to the bones. Denosumab has an approximate molecular weight of 147 kDa and is produced in genetically engineered mammalian Chinese hamster ovary cells.